Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is N/A as of 2026-10-06T19:54:25.532Z.
Calculation as of: 2026-10-06T19:54:25.532Z.
Quote observation: 2026-10-06T19:38:52.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cafac005872c57a3e4a0b6cd3f460881363b31539507c7b963fc5044b4159481
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-17.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
N/A
EV/ASSETS RATIO AVG TTM
N/A
EV/ASSETS RATIO AVG 3Y
N/A
EV/ASSETS RATIO AVG 5Y
N/A
EV/ASSETS RATIO AVG 10Y
N/A
EV/ASSETS RATIO AVG 15Y
N/A
EV/ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$556226.00
EV/Assets Ratio
0.24x
TTM Avg
0.31x
3Y Avg
21.31x
5Y Avg
35.49x
Market Cap
$479001.00
EV/Assets Ratio
N/A
TTM Avg
0.77x
3Y Avg
2.21x
5Y Avg
2.24x
Market Cap
$401484.00
EV/Assets Ratio
0.02x
TTM Avg
0.35x
3Y Avg
0.63x
5Y Avg
0.83x
Market Cap
$701131.00
EV/Assets Ratio
0.28x
TTM Avg
1.04x
3Y Avg
147.08x
5Y Avg
150.16x
Market Cap
$358320.00
EV/Assets Ratio
N/A
TTM Avg
0.07x
3Y Avg
0.53x
5Y Avg
111.37x
Market Cap
$734483.00
EV/Assets Ratio
N/A
TTM Avg
940.44x
3Y Avg
3406.08x
5Y Avg
11174.06x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| VivoSim Labs, Inc. (VIVS) | $527596.00 | N/A | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB)vs › | $556226.00 | 0.24x | 0.31x | 21.31x | 35.49x |
| XORTX Therapeutics Inc. (XRTX)vs › | $479001.00 | N/A | 0.77x | 2.21x | 2.24x |
| Niki BioSolutions, Inc. (NIKI)vs › | $401484.00 | 0.02x | 0.35x | 0.63x | 0.83x |
| CDT Equity Inc. (CDT)vs › | $701131.00 | 0.28x | 1.04x | 147.08x | 150.16x |
| Virax Biolabs Group Limited (VRAX)vs › | $358320.00 | N/A | 0.07x | 0.53x | 111.37x |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $734483.00 | N/A | 940.44x | 3406.08x | 11174.06x |
| SciSparc Ltd. (SPRC)vs › | $246973.00 | N/A | 0.58x | 7.17x | 51.17x |
| Ridgetech, Inc. (RDGT)vs › | $827005.00 | N/A | 0.25x | 0.25x | 0.26x |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $827668.00 | N/A | 0.06x | 20.82x | 97.85x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-09-17 | 0.00x |
| 2026-09-16 | 0.01x |
| 2026-09-15 | 0.02x |
| 2026-09-14 | 0.03x |
| 2026-09-11 | 0.03x |
| 2026-09-10 | 0.06x |
| 2026-09-09 | 0.02x |
| 2026-09-08 | 0.03x |
| 2026-09-04 | 0.03x |
| 2026-09-03 | 0.03x |
| 2026-09-02 | 0.03x |
| 2026-09-01 | 0.03x |
| 2026-08-31 | 0.04x |
| 2026-08-28 | 0.04x |
| 2026-08-27 | 0.05x |
| 2026-08-26 | 0.04x |
| 2026-08-25 | 0.05x |
| 2026-08-24 | 0.05x |
| 2026-08-21 | 0.04x |
| 2026-08-20 | 0.03x |
| 2026-08-19 | 0.03x |
| 2026-08-18 | 0.03x |
| 2026-08-17 | 0.08x |
| 2026-08-14 | 0.09x |
| 2026-08-13 | 0.09x |
| 2026-02-05 | 0.01x |
| 2026-02-03 | 0.05x |
| 2026-01-30 | 0.08x |
